ENZON PHARMACEUTICALS, INC. Quarterly Other Assets, Current in USD from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
Enzon Pharmaceuticals, Inc. quarterly Other Assets, Current history and growth rate from Q4 2010 to Q2 2024.
  • Enzon Pharmaceuticals, Inc. Other Assets, Current for the quarter ending June 30, 2024 was $409K, a 15.5% increase year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $409K +$55K +15.5% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $481K +$101K +26.6% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $331K -$74K -18.3% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $329K -$76K -18.8% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $354K -$76K -17.7% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $380K +$339K +827% Mar 31, 2023 10-Q 2023-05-05
Q4 2022 $405K +$320K +376% Dec 31, 2022 10-K 2024-03-20
Q3 2022 $405K +$333K +463% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $430K +$375K +682% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $41K +$1K +2.5% Mar 31, 2022 10-Q 2022-04-26
Q4 2021 $85K +$26K +44.1% Dec 31, 2021 10-K 2023-02-16
Q3 2021 $72K +$16K +28.6% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $55K -$40K -42.1% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $40K -$83K -67.5% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $59K -$3K -4.84% Dec 31, 2020 10-K 2022-02-25
Q3 2020 $56K -$58K -50.9% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $95K -$1K -1.04% Jun 30, 2020 10-Q 2020-07-29
Q1 2020 $123K +$67K +120% Mar 31, 2020 10-Q 2020-04-30
Q4 2019 $62K -$8K -11.4% Dec 31, 2019 10-K 2021-02-23
Q3 2019 $114K +$46K +67.6% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $96K -$8K -7.69% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $56K -$64K -53.3% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $70K -$24K -25.5% Dec 31, 2018 10-K 2020-02-19
Q3 2018 $68K -$16K -19% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 $104K -$23K -18.1% Jun 30, 2018 10-Q 2018-08-10
Q1 2018 $120K -$161K -57.3% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $94K -$176K -65.2% Dec 31, 2017 10-K 2019-02-21
Q3 2017 $84K -$150K -64.1% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $127K -$151K -54.3% Jun 30, 2017 10-Q 2017-08-10
Q1 2017 $281K +$237K +539% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 $270K +$163K +152% Dec 31, 2016 10-K 2018-03-21
Q3 2016 $234K -$70K -23% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 $278K -$335K -54.6% Jun 30, 2016 10-Q 2016-08-10
Q1 2016 $44K -$439K -90.9% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 $107K -$371K -77.6% Dec 31, 2015 10-K 2017-03-24
Q3 2015 $304K -$25K -7.6% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 $613K +$189K +44.6% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 $483K +$184K +61.5% Mar 31, 2015 10-Q 2015-05-13
Q4 2014 $478K -$33K -6.46% Dec 31, 2014 10-K 2016-03-21
Q3 2014 $329K -$313K -48.8% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 $424K -$866K -67.1% Jun 30, 2014 10-Q 2014-08-08
Q1 2014 $299K -$1.65M -84.7% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 $511K -$1.39M -73.2% Dec 31, 2013 10-K 2015-03-05
Q3 2013 $642K -$1.59M -71.3% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 $1.29M -$1.77M -57.8% Jun 30, 2013 10-Q 2013-08-06
Q1 2013 $1.95M -$507K -20.6% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 $1.9M -$845K -30.7% Dec 31, 2012 10-K 2014-03-14
Q3 2012 $2.24M -$684K -23.4% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 $3.06M -$1.13M -27% Jun 30, 2012 10-Q/A 2012-08-21
Q1 2012 $2.46M Mar 31, 2012 10-Q 2012-05-02
Q4 2011 $2.75M -$3.17M -53.5% Dec 31, 2011 10-K 2013-03-18
Q3 2011 $2.92M Sep 30, 2011 10-Q 2011-11-04
Q2 2011 $4.19M Jun 30, 2011 10-Q 2011-08-05
Q4 2010 $5.92M Dec 31, 2010 10-K 2012-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.